Accessibility Menu
 
Novartis logo

Novartis

(NYSE) NVS

Current Price$144.46
Market Cap$263.95B
Since IPO (1991)+4,313%
5 Year+112%
1 Year+32%
1 Month-3%

Novartis Financials at a Glance

Market Cap

$263.95B

Revenue (TTM)

$56.15B

Net Income (TTM)

$13.98B

EPS (TTM)

$7.19

P/E Ratio

19.93

Dividend

$4.74

Beta (Volatility)

0.34 (Low)

Price

$144.46

Volume

36,304

Open

$144.02

Previous Close

$144.19

Daily Range

$142.73 - $144.57

52-Week Range

$104.93 - $170.46

NVS: Motley Fool Moneyball Superscore

76

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novartis

Industry

Pharmaceuticals

Employees

75,267

CEO

Vasant Narasimhan, MD

Headquarters

Basel, 4056, CH

NVS Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

31%

Net Income Margin

25%

Return on Equity

31%

Return on Capital

20%

Return on Assets

12%

Earnings Yield

5.02%

Dividend Yield

3.29%

Payout Ratio

53.54%

Stock Overview

Market Cap

$263.95B

Shares Outstanding

1.83B

Volume

36.30K

Avg. Volume

2.24M

Financials (TTM)

Gross Profit

$41.12B

Operating Income

$17.07B

EBITDA

$22.99B

Operating Cash Flow

$19.24B

Capital Expenditure

$1.56B

Free Cash Flow

$17.69B

Cash & ST Invst.

$11.59B

Total Debt

$37.03B

Novartis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$13.33B

-1.6%

Gross Profit

$9.79B

-4.3%

Gross Margin

73.44%

N/A

Market Cap

$263.95B

N/A

Market Cap/Employee

$3.48M

N/A

Employees

75,883

N/A

Net Income

$2.41B

-14.5%

EBITDA

$5.07B

-2.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$25.52B

-42.5%

Accounts Receivable

$10.93B

+33.2%

Inventory

$6.27B

+9.5%

Long Term Debt

$31.25B

+36.3%

Short Term Debt

$5.78B

-30.5%

Return on Assets

12.13%

N/A

Return on Invested Capital

19.92%

N/A

Free Cash Flow

$1.64B

-46.3%

Operating Cash Flow

$2.25B

-46.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRKMerck & Co., Inc.
$111.68+1.32%
AZNAstraZeneca PLC
$187.40-0.06%
RHHBYRoche Holding AG
$50.58-1.25%
ABBVAbbVie Inc.
$198.57+0.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$212.31-0.02%
POETPoet Technologies
$8.20+0.03%
NOKNokia
$10.96+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.26-0.00%

Questions About NVS

What is the current price of Novartis?

Novartis is trading at $144.46 per share.

What is the 52-week range for Novartis?

Over the past 52 weeks, Novartis has traded between $104.93 and $170.46.

How much debt does Novartis have?

As of the most recent reporting period, Novartis reported total debt of $35.38B.

How much cash does Novartis have on hand?

Novartis reported $11.44B in cash and cash equivalents in its most recent financial results.

What is Novartis’s dividend yield?

Novartis currently has a dividend yield of 3.29%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.